FHIR R4 BiologicallyDerivedProduct Library

Overview

This asset is a component of MuleSoft Accelerator for Healthcare.

MuleSoft Accelerator for Healthcare enables healthcare providers to unlock critical patient data to build a patient 360 within Salesforce Health Cloud, faster and easier than ever before. The solution includes pre-built APIs, connectors, integration templates, and prescriptive end-to-end reference architecture to bring patient demographics information and COVID-19 test results from any EHR into Health Cloud using HL7 V2 or FHIR standards.

The solution also provides a library of United States Core Data for Interoperability (USCDI) and FHIR R4 resources to help healthcare developers adhere to interoperability needs and jumpstart the development of healthcare digital transformation initiatives.

Use case covered

Trial-Use Note: Note that this content is preliminary has not undergone proper review by the appropriate Workgroups.

A material substance originating from a biological entity intended to be transplanted or infused into another (possibly the same) biological entity.

Examples include:

• hematopoietic stem cells (bone marrow, peripheral blood, or cord blood extraction)
• blood (whole, extracted cells, plasma, etc.)
• organs
• tissues (porcine valves, skin, bovine cardiac tissue, etc.)
• manipulated cells (e.g. CAR T-cells)

The workflow using this resource (e.g., request, administration) should be discussed and implemented in a consistent way as other similar resources are handled (e.g., device, medication)

This library is used by FHIR R4 BiologicallyDerivedProduct API.

More information about FHIR R4 BiologicallyDerivedProduct specification can be found here.